989.92KUSD
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US29137T1016
CUSIP
12619C101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.92
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.07
Wall Street Target Price
4.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
16,553,000
Gross Profit TTM
15,384,000
EBITDA
-113,000
Profit Margin
-26.79%
Return On Assets TTM
-0.32%
Return On Equity TTM
0.00%
Revenue Per Share TTM
0.26
Qtly Revenue Growth YOY
-4.00%
Diluted Eps TTM
-0.07
Qtly Earnings Growth YOY
2219.60%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.0598
Price Book MRQ
0
Enterprise Value Revenue
1
Enterprise Value EBITDA
70
545.28
1.34%519.60
1.21%78.99
1.04%586.54
0.00%148.56
0.00%186.29
-1.96%89.37
-1.20%252.80
-0.50%448.40
-0.03%312.01
-0.03%